Good morning , Graham and Megan here this morning as Paul is off.

Summaries

Allied Minds (LON:ALM) (£26m) (-42%) [no section below] - let’s put a full stop on the story of Allied Minds. This was a Woodford-backed venture which at one point in 2015 had a market cap of over £1.5 billion. It’s a collection of blue-sky technology investments, as the underlying companies have typically been in the research phase, i.e. quite a long way from generating any revenues. The thesis was that at least some of these investments would succeed, and that a patient, long-term ALM shareholder would do well. Unfortunately, we have now arrived at the long-run destination and it’s a possible delisting: “the costs of maintaining a premium listing on the Official List and the Main Market of the London Stock Exchange are now prohibitively high”. Cash has dwindled to $9.7m (December 2021 balance sheet) plus a few million dollars from a disposal. ALM’s portfolio now has just five companies and it is surely a matter of time before ALM winds itself up - whether or not it keeps its LSE listing.

Sopheon (LON:SPE) (£68m) ($80m) (-1%) [no section below] - This enterprise software group shows an H1 operating loss, albeit a small loss ($0.8m) in the context of the company’s overall size. I find it frustrating that the company refuses to acknowledge the loss in its headlines, only mentioning that adjusted EBITDA was $2.9m (last year: $2.8m). Management appear overly keen to portray Sopheon in a positive light, despite reported revenues falling (to $15.7m). The type of contract signed with customers has changed, and the company says this is to blame for the lower amount of revenue recognised. Many other factors combine to bring about these poor results: unfavourable currency fluctuations, salary inflation, a small impairment provision against development costs, and large share-based payments ($3.7m, which are excluded from adjusted EBITDA).

Sopheon does have a large net cash position ($23.5m), which is just as well since it has capitalised $3m of development costs in this six-month period, i.e. these are costs that are not included in the latest operating loss. I still suspect Sopheon has a decent underlying business, but it is requiring enormous patience. Annualised recurring revenue has reached $21.9m, so the market cap (ex-cash) works out at around 2.5x recurring revenues. At least this valuation isn’t too frothy; this…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here